Evidence map›Paper›PMID 40185919›Full record

ArticleInsights into imaging2025

CT-based radiomics deep learning signatures for non-invasive prediction of metastatic potential in pheochromocytoma and paraganglioma: a multicohort study.

Yongjie Zhou, Yuan Zhan, Jinhong Zhao, Linhua Zhong, Fei Zou, Xuechao Zhu, Qiao Zeng, Jiayu Nan, Lianggeng Gong, Yongming Tan and 1 more

Abstract read
In one paragraph

Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yongjie ZhouDepartment of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Yuan ZhanDepartment of Pathology and Institute of Molecular Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Jinhong ZhaoDepartment of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Linhua ZhongDepartment of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Fei ZouDepartment of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Xuechao ZhuDepartment of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Qiao ZengDepartment of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Jiayu NanDepartment of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Lianggeng GongDepartment of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yongming Tan *Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. ndfyf04394@ncu.edu.cn.
Lan Liu *Department of Radiology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China. zhou919986102@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to develop and validate CT-based radiomics deep learning signatures for the non-invasive prediction of metastatic potential in pheochromocytomas and paragangliomas (PPGLs).

methodsWe conducted a retrospective analysis of 249 PPGL patients from three institutions, dividing them into training (n = 138), test1 (n = 71), and test2 (n = 40) sets. Based on the grading system for adrenal pheochromocytoma and paraganglioma (GAPP), patients were classified into low-risk (GAPP < 3) and high-risk (GAPP ≥ 3) groups. Radiomic features were extracted from CT venous phase images and modeled using six machine learning algorithms. The maximum 2D sections and 3D images of each tumor were input into four ResNet models to obtain predictive probabilities. Optimal models were selected based on receiver operating characteristic analysis and integrated with radiological features to develop a combined model, which was evaluated on external datasets, and explored prognostic information.

resultsThe support vector machine radiomics and 2D ResNet-50 models demonstrated good performance. By integrating these two models with intratumoral necrosis features, we constructed a combined model that achieved high accuracy, with area under the curve (AUC) values of 0.90 for the training, 0.86 for the test1, and 0.88 for the test2 sets. This model effectively stratified patients based on metastasis-free survival (p = 0.003). Its predictive ability remains robust below the 6 cm threshold, with AUC values exceeding 0.87 across all datasets.

conclusionsThe combined model can predict the metastatic potential of PPGL in the preoperative stage, providing a precise surgical strategy for pheochromocytoma regarding the 6 cm surgical threshold. CRITICAL RELEVANCE STATEMENT: The combined model, established based on radiomic and deep learning signatures, shows potential for early preoperative prediction of metastatic potential in PPGL. KEY POINTS: Metastatic potential of PPGL affects surgical approaches and prognosis. CT-based radiomics deep learning signatures can predict the metastatic potential in PPGL.3. The combined model's predictive ability remains robust below the 6-cm threshold. The combined model's predictive ability remains robust below the 6-cm threshold.

Indexed as

Deep learningMetastatic potentialParagangliomaPheochromocytomaRadiomics

Identifiers

PMID40185919
PMCPMC11971077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.